Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Black Hawk Acquisition Corp
Black Hawk Acquisition Corp deposited $150,000 into its trust account to extend the deadline for consummating its initial business combination. This action extends the period to complete the business combination by one month, from October 22, 2026, to November 22, 2026.…more
Black Hawk Acquisition Corp
Black Hawk Acquisition Corp held an extraordinary general meeting on October 13, 2026, where shareholders approved all eight proposals, including the business combination with Vesicor Therapeutics and the company's domestication. In connection with the meeting, shareholders exercised redemption rights for 2,089,162 shares at a price of approximately $12.04 per share, totaling $25,153,510.48.…more
Black Hawk Acquisition Corp
Wolverine Asset Management LLC has filed a SCHEDULE 13G/A, providing an update on its beneficial ownership stake in Black Hawk Acquisition Corp. This filing serves as a routine disclosure regarding the investor's position in the company.…more
16 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Black Hawk Acquisition Shareholders Approve Merger with Vesicor Therapeutics…more
Black Hawk Acquisition shareholders have officially approved the proposed business combination with Vesicor Therapeutics. This vote marks a key milestone in the completion of the merger agreement between the two companies.…more
●●●●●●●● ●●●●● ●●●●●●
Black Hawk Acquisition is proceeding with its merger with Vesicor Therapeutics and has secured a forward purchase agreement for up to 1.35 million shares with Meteora. The deal includes a potential $200 million equity financing facility over 36 months, which may lead to shareholder dilution.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.